๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for FL Lymphoma

Phase II Study of Artesunate Ointment for the Treatment of Vulvar High Grade Squamous Intraepithelial Lesions (Vulvar HSIL, VIN2/3) NCT06075264Phase 25 sites๐Ÿ“ Fort Myers๐Ÿ“ Indianapolis๐Ÿ“ Cleveland Frantz Viral Therapeutics, LLC ยท Tests: Artesunate ointment, Placebo ointment Lenalidomide Combined With G-CHOP in the Treatment of Newly Diagnosed DLBCL With FL NCT06151080Phase 21 site๐Ÿ“ Xiamen The First Affiliated Hospital of Xiamen University ยท Tests: Lenalidomide combined with G-CHOP (LO CHOP) A Real-world Study of Obinutuzumab-based Therapy for Previously Untreated FL NCT05899621n/a1 site๐Ÿ“ Shanghai Ruijin Hospital ยท Tests: Obinutuzumab, Lenalidomide, Bendamustine, Cyclophosphamide, Doxorubicin Epco, Zanu, Ritux for R/R FL or MZL NCT06563596Phase 23 sites๐Ÿ“ Boston๐Ÿ“ New York๐Ÿ“ Columbus Reid Merryman, MD ยท Tests: Zanubrutinib, Rituximab, Epcoritamab Optimizing ctDNA-based MRD Assessment in DLBCL, MCL, and FL Patients Undergoing CAR Therapy NCT05255354n/a1 site๐Ÿ“ Palo Alto Adaptive Biotechnologies ยท Tests: ClonoSEQ Multidimensional Phenotype Classification in Grade 3 Bronchopulmonary Dysplasia NCT06475976n/a1 site๐Ÿ“ Philadelphia Children's Hospital of Philadelphia ยท Tests: Chest computed tomography (CT) with angiography, Bronchoscopy with bronchoalveolar lavage, Echocardiography, 24 hour esโ€ฆ Odronextamab in Low Tumor Volume Advanced FL NCT07128641Phase 21 site๐Ÿ“ Boston Gottfried von Keudell, MD PhD ยท Tests: Odronextamab Long-term Follow up Local Registry Study of Kymriah in South Korea NCT06785818n/a18 sites๐Ÿ“ Bundang Gu๐Ÿ“ Seongnam-si๐Ÿ“ Gyeonggi-do Novartis Pharmaceuticals ยท Tests: Tisagenlecleucel Tafasitamab and Rituximab for the Treatment of Newly Diagnosed Follicular Lymphoma NCT07731789Phase 21 site๐Ÿ“ Seattle University of Washington ยท Tests: Rituximab, Tafasitamab, Biospecimen Collection, Bone Marrow Aspiration, Bone Marrow Biopsy Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer NCT01137643n/a1 site๐Ÿ“ Chapel Hill UNC Lineberger Comprehensive Cancer Center ยท Tests: biologic sample preservation procedure, cytology specimen collection procedure Triapine in Combination With Temozolomide for the Treatment of Patients With Recurrent Glioblastoma NCT06410248Phase 11 site๐Ÿ“ Chicago Northwestern University ยท Tests: Biospecimen Collection, Magnetic Resonance Imaging, Questionnaire Administration, Resection, Temozolomide A Study to Evaluate Safety, PK, PD and Efficacy of AZD5492, a T Cell-engaging Antibody Targeting CD20 in Subjects With R/R B-Cell Malignancies. NCT06542250Phase 1, Phase 231 sites๐Ÿ“ La Jolla๐Ÿ“ Boston๐Ÿ“ Rochester AstraZeneca ยท Tests: AZD5492 Epcoritamab (Epcor)-Containing Combination Salvage Therapy Followed by ASCT & Epcor Consolidation in Patients With Relapsed LBCL NCT06287398Phase 21 site๐Ÿ“ Melbourne Australasian Leukaemia and Lymphoma Group ยท Tests: Epcoritamab Prediction of Intraventricular Hemorrhage Using Echocardiography and Near Infrared Spectroscopy NCT05708105n/a4 sites๐Ÿ“ Calgary๐Ÿ“ Edmonton๐Ÿ“ London Mount Sinai Hospital, Canada ยท Tests: Cerebral near-infrared spectroscopy, Functional echocardiography, Head Ultrasound A Study of ARC-02 in B-cell NHL NCT07691606Phase 129 sites๐Ÿ“ Los Angeles๐Ÿ“ Louisville๐Ÿ“ New York Taiho Oncology, Inc. ยท Tests: ARC-02, Rituximab An Investigational Scan (Ga-68 PSMA-11 PET/CT) for Detection of Disease Recurrence or Progression in Patients With Glioma NCT06444412Phase 21 site๐Ÿ“ Rochester Mayo Clinic ยท Tests: Computed Tomography, Electronic Health Record Review, Ga 68 PSMA-11, Positron Emission Tomography A Study to Evaluate the Safety and Efficacy of SCTB35 in Combination With Lenalidomide in Patients With Relapsed or Refractory Follicular Lymphoma NCT07562022Phase 31 site๐Ÿ“ Beijing Sinocelltech Ltd. ยท Tests: SCTB35 injection, Rituximab, Lenalidomide A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies NCT04830137Phase 116 sites๐Ÿ“ Duarte๐Ÿ“ Orange๐Ÿ“ San Francisco Nurix Therapeutics, Inc. ยท Tests: NX-2127 SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance) NCT05303519Phase 361 sites๐Ÿ“ Birmingham๐Ÿ“ Phoenix๐Ÿ“ Phoenix Nuvation Bio Inc. ยท Tests: safusidenib, Placebo NexCAR19 (Talikabtagene Autoleucel) in Relapsed/Refractory B-Cell Malignancies (NexCAR19) NCT07502118Phase 2, Phase 34 sites๐Ÿ“ Ankara๐Ÿ“ Ankara๐Ÿ“ Ankara Health Institutes of Turkey ยท Tests: Talikabtagene Autoleucel HM2023-43:Ph 2 Trial of Tafasitamab With Lenalidomide+Rituximab in Treatment-naive FL and MZL NCT06792825Phase 21 site๐Ÿ“ Minneapolis Masonic Cancer Center, University of Minnesota ยท Tests: Tafasitamab, Rituximab, Lenalidomide SVV-001 With Nivolumab and Ipilimumab in Patients With Poorly Differentiated Neuroendocrine Carcinomas (NEC) or Well-Differentiated High-Grade Neuroendocrine Tumors (NET) NCT06889493Phase 11 site๐Ÿ“ Miami Peter Hosein, MD ยท Tests: Seneca Valley Virus-001 (SVV-001), Nivolumab, Ipilimumab Orelabrutinib Plus Rituximab Followed by Maintenance With Orelabrutinib for Relapsed and Refractory Follicular Lymphoma(RR FL) NCT04989621Phase 23 sites๐Ÿ“ Guangzhou๐Ÿ“ Guangzhou๐Ÿ“ Guangzhou Sun Yat-sen University ยท Tests: Orelabrutinib and Rituximab, Orelabrutinib Registry Platform Hematologic Malignancies (RUBIN) - Extension of Tumor Registry Lymphatic Neoplasms NCT06043011n/a1 site๐Ÿ“ Freiburg im Breisgau iOMEDICO AG ยท Tests: Routine care as per site standard. A Study of Zanzalintinib in Participants With Recurrent or Progressive Meningioma NCT07428616Phase 220 sites๐Ÿ“ Birmingham๐Ÿ“ Phoenix๐Ÿ“ San Francisco Exelixis ยท Tests: Zanzalintinib Dose Escalation and Dose Expansion Study of MDX2003 in Patients With Different Types of Lymphoma NCT07249905Phase 1, Phase 26 sites๐Ÿ“ Richmond๐Ÿ“ Nedlands๐Ÿ“ Haifa ModeX Therapeutics, An OPKO Health Company ยท Tests: MDX2003 Sample Collection for Ongoing Research and Product Evaluation Study - Non-Hodgkin Lymphoma (SCORE-NHL) NCT07750886n/a1 site๐Ÿ“ Austin Natera, Inc. Lutathera for the Treatment of Inoperable, Progressive Meningioma After External Beam Radiation Therapy NCT04082520Phase 21 site๐Ÿ“ Rochester Mayo Clinic ยท Tests: Gallium Ga 68-DOTATATE, Lutetium Lu 177 Dotatate, Magnetic Resonance Imaging, Positron Emission Tomography, Questionnaiโ€ฆ Intracranial Genetically Modified Immune Cells (TGFฮฒR2KO/IL13Rฮฑ2 CAR T-Cells) for the Treatment of Recurrent or Progressive Glioblastoma or Grade 3 or 4 IDH-Mutant Astrocytoma NCT06815029Phase 11 site๐Ÿ“ Duarte City of Hope Medical Center ยท Tests: Biospecimen Collection, Chimeric Antigen Receptor T-Cell Therapy, Echocardiography, Fludeoxyglucose F-18, Intracranial โ€ฆ Treatment of Chinese Participants With B-Cell Malignancies With BGB-16673, a Bruton Tyrosine Kinase-Targeted Protein-Degrader NCT05294731Phase 1, Phase 229 sites๐Ÿ“ Bengbu๐Ÿ“ Hefei๐Ÿ“ Beijing BeOne Medicines ยท Tests: Tacabrutideg
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy